3Blum RA. Lansoprazole and omeprazole in the treatment of acid peptic disorders. Am J Health Syst Pharm ,1996, 53:1401-1415.
4Barth J, Hahne W. Review article: rabeprazole-based therapy in Helicobacter pylori eradication. Aliment Pharmacol Ther, 2002, 16(Suppl 1 ) :31-33.
5Nakajima N, Kuwayama H, Iwasaki A, et al. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth. J Clin Gastroenterol, 1995, 20( Suppl 2) :S90-92.
6Robinson M. Proton pump inhibitors : update on their role in acid-related gastrointestinal diseases. Int J Clin Pract, 2005, 59:709-715.
7Vakil N, Lanza F, Schwartz H, et al. Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther, 2004,20:99-107.
8Hillman LC, Chiragakis L, Shadbolt B, et al. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med J Aust,2004,180:387-391.
9Yearsley KA, Gilby LJ, Ramadas AV, et al. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea.Aliment Pharmacol The, 2006, 24:613-619.
